Kombinált cisplatin-tartalmú kemoterápia randomizált vizsgálata a fej-nyak régióban lévó planocellularis rákok kezelésében.

Translated title of the contribution: Randomized study of cisplatin-based combination chemotherapy for the treatment of planocellular cancer of the head and neck region

L. Olasz, A. Németh, Z. Nyárády, T. Tornóczky, L. Királyfalvi

Research output: Contribution to journalArticle

2 Citations (Scopus)


Between January 1996 and November 1998 38 patients were treated with induction chemotherapy. Patients were distributed in two randomized groups, 19-19 patients in each, receiving (group N) either bleomycin, vincristine and methotrexate (BVM) or the previous medication plus cisplatin (BVCM) chemotherapy (group C). Side effects were low and reversible during the treatments. The clinical regression rate (RR) of the cases was 87% including complete regression 24%. There was no difference between the two groups. There was no difference in the pathological macroscopic regression, however group C was better in microscopic regression. During the 27.5 months of average follow-up time, group N had a significantly better result in the tumor-free survival, with a lower rate of metastatic recidives (N/C = 2/9). There was no significant difference in the overall survival rate, due to the radical neck dissections of recidive metastases. According to our experience we recommend the use of cisplatin in conjunction with neck radiotherapy.

Original languageHungarian
Pages (from-to)2433-2437
Number of pages5
JournalOrvosi hetilap
Issue number45
Publication statusPublished - Nov 5 2000


ASJC Scopus subject areas

  • Medicine(all)

Cite this